Soumili Chatterjee is a Principal Scientist currently at Pfizer, where they focus on analytical development. They previously served as a Senior Scientist at Seagen and have extensive experience in antibody therapeutics, including research on protein engineering and drug modulation. Soumili holds a Ph.D. in Physiology and Biophysics from Case Western Reserve University, where their dissertation studied voltage-gated sodium channels. In addition to their research, Soumili has actively facilitated clinical case inquiries for medical students and engaged in community science literacy initiatives.
This person is not in the org chart
This person is not in any teams
This person is not in any offices